Cargando…
CanB, a Druggable Cellular Target in Mycobacterium tuberculosis
[Image: see text] Treatment against tuberculosis can lead to the selection of drug-resistant Mycobacterium tuberculosis strains. To tackle this serious threat, new targets from M. tuberculosis are needed to develop novel effective drugs. In this work, we aimed to provide a possible workflow to valid...
Autores principales: | Degiacomi, Giulia, Gianibbi, Beatrice, Recchia, Deborah, Stelitano, Giovanni, Truglio, Giuseppina Ivana, Marra, Paola, Stamilla, Alessandro, Makarov, Vadim, Chiarelli, Laurent Robert, Manetti, Fabrizio, Pasca, Maria Rosalia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10357428/ https://www.ncbi.nlm.nih.gov/pubmed/37483251 http://dx.doi.org/10.1021/acsomega.3c02311 |
Ejemplares similares
-
Mycobacterium abscessus Infections in Cystic Fibrosis Individuals: A Review on Therapeutic Options
por: Recchia, Deborah, et al.
Publicado: (2023) -
The Antimalarial Mefloquine Shows Activity against Mycobacterium abscessus, Inhibiting Mycolic Acid Metabolism
por: Degiacomi, Giulia, et al.
Publicado: (2021) -
Mycobacterium abscessus, an Emerging and Worrisome Pathogen among Cystic Fibrosis Patients
por: Degiacomi, Giulia, et al.
Publicado: (2019) -
New Drugs and Novel Cellular Targets against Tuberculosis
por: Degiacomi, Giulia, et al.
Publicado: (2022) -
The Veterinary Anti-Parasitic Selamectin Is a Novel Inhibitor of the Mycobacterium tuberculosis DprE1 Enzyme
por: Ezquerra-Aznárez, José Manuel, et al.
Publicado: (2022)